Pulmonology

Your Article Summary

See Latest Articles

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation, 10/23/09

Jazieh AR et al. – This study aim was to determine the efficacy and safety of the combination of Gemcitabine 1000mg/m^2 day 1 & 8 and Irinotecan 100 mg/m^2 day 1 & 8 with escalating dose of thalidomide in chemonaive patients with advanced non–small cell lung cancer. The 1 year and 2 year survival rates were 36% and 27%, respectively. This combination is active in advanced NSCLC with manageable toxicity profile.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09

Magnesium sulphate in the treatment of acute asthma: evaluation of current practice in adult emergency departments
Emergency Medicine Journal, 10/27/09

A Randomized Trial of Nebulized 3% Hypertonic Saline With Epinephrine in the Treatment of Acute Bronchiolitis in the Emergency Department
Archives of Pediatrics and Adolescent Medicine, 11/23/09

See All of Clinical Pharmacology

Today in Lung/Thoracic Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer
Journal of Clinical Oncology, 10/29/09

New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09

Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Journal of Clinical Oncology, 11/05/09

See All of Lung/Thoracic Oncology